✦ LIBER ✦

Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients

✍ Scribed by M.H Shah; M.Z.M Bokhari; M.T.M Bokhari; A Farooq; S.M Yousaf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low rate of acute rejection and cytomega

✍ I. Folkmane; J. Bicans; D. Amerika; S. Chapenko; M. Murovska; R. Rosentals 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Basiliximab and Mycophenolate Mofetil in

✍ D. Kovac; V. Kotnik; A. Kandus 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 74 KB

The economics of basiliximab (Simulect)

✍ James B. Chilcott,Michael W. Holmes,Stephen Walters… 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 296 KB

The economics of basiliximab (Simulect)

✍ James B. Chilcott; Michael W. Holmes; Stephen Walters; Ronald L. Akehurst; Björn 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 666 KB

Efficacy and safety of antithymocyte glo

✍ E. Bertoni; M. Maccario; M. Biagini; G. Montagnino; R. Piperno; A. Tarantino; M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Efficacy and safety of tacrolimus versus

✍ M. El-Ghoroury; S. Hariharan; V.R. Peddi; R. Munda; T.J. Schroeder; A.M. Demmy; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 243 KB